drugset / Trial / NCT01443338

Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2

NCT01443338

Phase 4 Unknown 720 enrolled Ministry of Health, China
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether Triptergium wilfordii, and Acitretin are effective and safe in the treatment of patient of moderate to severe psoriasis vulgaris.

Timeline

Start
2011-09
Primary completion
2012-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acitretin Small molecule 30 mg
Comparator Triptergium Wilfordii Traditional medicine (herbal / TCM) 20 mg

Indications